<?xml version="1.0" encoding="UTF-8"?>
<ref id="B326-viruses-12-00110">
 <label>326.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hutterer</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Niemann</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Milbradt</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Fröhlich</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Reiter</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Kadioglu</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Bahsi</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Zeittrager</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Wagner</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Einsiedel</surname>
    <given-names>J.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>The broad-spectrum antiinfective drug artesunate interferes with the canonical nuclear factor kappa B (NF-κB) pathway by targeting RelA/p65</article-title>
  <source>Antivir. Res.</source>
  <year>2015</year>
  <volume>124</volume>
  <fpage>101</fpage>
  <lpage>109</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2015.10.003</pub-id>
  <pub-id pub-id-type="pmid">26546752</pub-id>
 </element-citation>
</ref>
